Aspartika Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 09-12-2024
- Paid Up Capital ₹ 1.20 M
as on 09-12-2024
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 1.21 Cr
as on 09-12-2024
- Revenue 12.46%
(FY 2022)
- Profit 9.92%
(FY 2022)
- Ebitda -9.33%
(FY 2022)
- Net Worth 5.38%
(FY 2022)
- Total Assets 5.31%
(FY 2022)
About Aspartika Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.20 M.
The company currently has active open charges totaling ₹1.21 Cr.
Bandlamuri Srinivas and Sujit Ghosh serve as directors at the Company.
- CIN/LLPIN
U24232KA2015PTC079484
- Company No.
079484
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Mar 2015
- Date of AGM
30 Dec 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore Rural, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Aspartika Biotech Private Limited offer?
Aspartika Biotech Private Limited offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Animal Feed Supplement, Essential & Aromatic Oils, Herb Oil.
Who are the key members and board of directors at Aspartika Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bandlamuri Srinivas  | Director | 25-Mar-2015 | Current |
| Sujit Ghosh | Director | 20-Aug-2018 | Current |
Financial Performance and Corporate Structure Insights of Aspartika Biotech.
Aspartika Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 12.46% increase. The company also saw a slight improvement in profitability, with a 9.92% increase in profit. The company's net worth moved up by a moderate rise of 5.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aspartika Biotech?
Unlock access to Aspartika Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 18 Nov 2017 | ₹1.21 Cr | Open |
How Many Employees Work at Aspartika Biotech?
Unlock and access historical data on people associated with Aspartika Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aspartika Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aspartika Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
